Loading...
Fulvestrant in advanced breast cancer: evidence to date and place in therapy
Breast cancer is a classical hormone-dependent tumour; therefore, endocrine therapy is the mainstay of treatment for hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer. Until recently, classical endocrine agents such as tamoxifen, steroidal and nonsteroidal ar...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502950/ https://ncbi.nlm.nih.gov/pubmed/28717399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017711097 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|